{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_017633.3:c.6056A>T",
          "cDNA Change": {
            "transcript": "NM_017633.3",
            "ref": "A",
            "alt": "T",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S (c.6056A>T) variant in LRRK2"
        },
        {
          "HGVS": "NM_017633.3:c.4322G>T",
          "cDNA Change": {
            "transcript": "NM_017633.3",
            "ref": "G",
            "alt": "T",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C (c.4322G>T) variant in LRRK2"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005253"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells expressing LRRK2 variants were used for Western blot analysis."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017633.3:c.6056A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation of LRRK2 at Ser935 in G2019S variant compared to wild-type."
        },
        {
          "Variant": "NM_017633.3:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Elevated kinase activity in R1441C variant compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing HEK293 cells were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected HEK293 cells were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels ≤ 150% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels > 150% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Kinase Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells overexpressing LRRK2 variants were used for kinase assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017633.3:c.6056A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "G2019S variant showed 2.3-fold increased kinase activity compared to wild-type."
        },
        {
          "Variant": "NM_017633.3:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441C variant exhibited 1.8-fold increased kinase activity compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were conducted for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was tested in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing SH-SY5Y cells served as positive controls."
      },
      "Basic negative control": {
        "Basic negative控制": "Yes",
        "Description": "Empty vector-transfected SH-SY5Y cells were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity ≤ 120% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity > 120% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}